You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tezepelumab

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tezepelumab PRO Study

Not yet recruiting
  • Asthma
    • (no location specified)
    Jun 20, 2023

    Asthma, Allergic Trial in Hamilton, Saskatoon (Tezepelumab, Placebo)

    Not yet recruiting
    • Asthma, Allergic
    • Tezepelumab
    • Placebo
    • Hamilton, Ontario, Canada
    • +1 more
    Feb 22, 2023

    Asthma Trial in Hamilton (Tezepelumab, Placebo)

    Recruiting
    • Asthma
    • Tezepelumab
    • Placebo
    • Hamilton, Ontario, Canada
      Firestone Institute for Respiratory Health
    Jan 18, 2023

    Airway Remodelling, Asthmatic Trial in France (Tezepelumab, )

    Not yet recruiting
    • Airway Remodelling, Asthmatic
    • Tezepelumab
    • placebo
    • Dijon, France
    • +11 more
    Jan 30, 2023

    Observing Severe Asthma in Patients Treated With Tezepelumab

    Recruiting
    • Asthma
    • None (Observational Study)
    • Toronto, Ontario, Canada
      Research Site
    Jan 23, 2023

    Healthy Volunteers Trial (Placebo, Tezepelumab)

    Completed
    Has Results
    • Healthy Volunteers
    • Placebo
    • Tezepelumab
    • (no location specified)
    Sep 8, 2022

    Severe Asthma Trial in Japan (Biological: Experimental: Tezepelumab)

    Completed
    Has Results
    • Severe Asthma
    • Biological: Experimental: Tezepelumab
    • Chuo-ku, Japan
    • +4 more
    May 9, 2022

    Atopic Dermatitis, Healthy Volunteers Trial (Tezepelumab, Placebo)

    Completed
    Has Results
    • Atopic Dermatitis
    • Healthy Volunteers
    • Tezepelumab
    • Placebo
    • (no location specified)
    Sep 8, 2022

    Moderate to Severe Asthma Trial in United States (Tezepelumab, Placebo)

    Completed
    • Moderate to Severe Asthma
    • Tezepelumab
    • Placebo
    • Bakersfield, California
    • +14 more
    Sep 28, 2022

    COPD, COPD Exacerbation, COPD Bronchitis Trial in Antwerp, Copenhagen, Leicester (Tezepelumab, Placebo)

    Not yet recruiting
    • COPD
    • +4 more
    • Tezepelumab
    • Placebo
    • Antwerp, Belgium
    • +2 more
    Aug 17, 2022

    Asthma Trial in Hungary, South Africa, United Kingdom (Tezepelumab)

    Recruiting
    • Asthma
    • Tezepelumab
    • Budapest, Hungary
    • +6 more
    Mar 18, 2022

    Asthma Trial in Worldwide (Tezepelumab, Placebo)

    Recruiting
    • Asthma
    • Tezepelumab
    • Placebo
    • Montgomery, Alabama
    • +38 more
    Aug 30, 2023

    Asthma Trial in United States (Tezepelumab)

    Recruiting
    • Asthma
    • Tezepelumab
    • Mobile, Alabama
    • +28 more
    Aug 2, 2022

    Eosinophilic Esophagitis Trial in Worldwide (Tezepelumab, Placebo)

    Recruiting
    • Eosinophilic Esophagitis
    • Tezepelumab
    • Placebo
    • Los Angeles, California
    • +95 more
    Jan 27, 2023

    Asthma Trial in Worldwide (Tezepelumab, Placebo)

    Not yet recruiting
    • Asthma
    • Tezepelumab
    • Placebo
    • Denver, Colorado
    • +48 more
    May 26, 2022

    Asthma, Bronchial Diseases, Respiratory Tract Diseases Trial in Worldwide (Tezepelumab, Placebo)

    Completed
    Has Results
    • Asthma
    • +8 more
    • Tezepelumab
    • Placebo
    • Denver, Colorado
    • +27 more
    Feb 18, 2022

    Healthy Subjects Trial in Nanchang (Experimental: Tezepelumab, Placebo)

    Completed
    • Healthy Subjects
    • Experimental: Tezepelumab
    • Placebo
    • Nanchang, China
      Research Site
    Nov 16, 2020

    Asthma Trial in Worldwide (Tezepelumab (APFS), Tezepelumab (AI))

    Completed
    Has Results
    • Asthma
    • Tezepelumab (APFS)
    • Tezepelumab (AI)
    • Hoover, Alabama
    • +35 more
    Jul 9, 2021

    Asthma Trial in Worldwide (Tezepelumab)

    Recruiting
    • Asthma
    • Tezepelumab
    • Newport Beach, California
    • +102 more
    Jan 11, 2023

    Chronic Rhinosinusitis With Nasal Polyps Trial in Worldwide (Experimental: Tezepelumab, Placebo)

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Experimental: Tezepelumab
    • Placebo
    • Birmingham, Alabama
    • +137 more
    Jan 4, 2023

    COPD (COPD) Trial in Worldwide (Tezepelumab, Placebo)

    Active, not recruiting
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Tezepelumab
    • Placebo
    • Dothan, Alabama
    • +90 more
    Jan 31, 2023

    Chronic Spontaneous Urticaria Trial in Worldwide (Tezepelumab Dose 1, Tezepelumab Dose 2, Omalizumab)

    Recruiting
    • Chronic Spontaneous Urticaria
    • Tezepelumab Dose 1
    • +3 more
    • Birmingham, Alabama
    • +81 more
    Aug 4, 2022

    Asthma Trial in Worldwide (Tezepelumab, Placebo)

    Completed
    Has Results
    • Asthma
    • Tezepelumab
    • Placebo
    • Bakersfield, California
    • +59 more
    Nov 10, 2021

    Atopic Dermatitis Trial in Worldwide (Tezepelumab, Placebo)

    Terminated
    Has Results
    • Atopic Dermatitis
    • Tezepelumab
    • Placebo
    • Fountain Valley, California
    • +85 more
    Mar 9, 2022

    Asthma Trial in Berlin (Tezepelumab)

    Completed
    • Asthma
    • Tezepelumab
    • Berlin, Germany
      Research Site
    Jan 7, 2020